US Patent 7981669 Viral vectors
Patent 7981669 was granted and assigned to Biovex Limited on July, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 29 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+317 characters)
Article
Patent abstract
The present invention provides a herpes virus which lacks a functional ICP34.5 encoding gene and which comprises two or more of—(i) a gene encoding a prodrug converting enzyme; (ii) a gene encoding a protein capable of causing cell to cell fusion; and (iii) a gene encoding an immunomodulatory protein.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Guy Richard Simpson0
Robert S. Coffin0
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07981669 Viral vectors US Patent 7981669 Viral vectors
Infobox
Patent Number
079816690
Patent Number
79816690
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079816690
Date of Patent
July 19, 2011
0Patent Application Number
113398040
Date Filed
January 25, 2006
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07981669 Viral vectors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07981669
Date of patent
July 19, 2011
Patent application number
11339804
Date Filed
January 25, 2006
Patent primary examiner
Find more entities like US Patent 7981669 Viral vectors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.